16:30 – 18:10
SESSION III: GENERAL TOPICS
| Chair: | Ander Urruticoechea, Onkologikoa, San Sebastian, Spain |
| 16:30 - 16:50 | Is breast cancer in very young women a different disease? Svasti Haricharan, San Diego State University, USA |
| 16:50 - 17:10 | Targeting cancer cell dormancy TBC, |
| 17:10 - 17:30 | Breast cancer in men TBC, |
| 17:30 - 17:50 | Aging in breast cancer survivors Jacob Kresovich, H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA |
| 17:50 - 18:10 | Discussion |
18:10 – 18:20
BREAK
18:20 – 20:00
SESSION IV: THERAPY OF BREAST CANCER II
| Chair: | Luis Costa, Hospital Santa María, Lisbon, Portugal |
| 18:20 - 18:40 | Omission of breast surgery after neoadjuvant systemic therapy in BC Henry M. Kuerer, MD Anderson Cancer Center, Houston, USA |
| 18:40 - 19:20 | De-escalating adjuvant therapy in HER2-positive early breast cancer Paolo Tarantino, Dana-Farber Cancer Institute, Boston, USA |
| 19:00 - 19:00 | Treatment of brain metastasis in HER2-positive breast cancer Guy Jerusalem, University of Liège, Belgium |
| 19:20 - 19:40 | Endocrine therapy of metastatic breast cancer: recent advances Erika Hamilton, Sarah Cannon Research Institute, Nashville, USA |
| 19:40 - 20:00 | Discussion |
20:00
Closing remarks
| Miguel Martin, Hospital General Universitario Gregorio Marañón, Madrid, Spain |